Activin A Stimulates Mouse APCs to Express BAFF via ALK4-Smad3 Pathway by Kim, Jae-Hee et al.
IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 4 August 2011
http://dx.doi.org/10.4110/in.2011.11.4.196
pISSN 1598-2629    eISSN 2092-6685
ORIGINAL ARTICLE
196
Received on June 23, 2011. Revised on July 7, 2011. Accepted on July 13, 2011.
CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribu-
tion, and reproduction in any medium, provided the original work is properly cited.
*Corresponding Author. Tel: 82-33-250-8546; Fax: 82-33-241-4627; E-mail: phkim@kangwon.ac.kr (Kim PH), gyseo@ 
kangwon.ac.kr (Seo GY)
Keywords: Activin A, BAFF, APCs, ALK4, Smad3, Ig class switch recombination
Activin A Stimulates Mouse APCs to Express BAFF via 
ALK4-Smad3 Pathway
Jae-Hee Kim
1, Goo-Young Seo
1* and Pyeung-Hyeun Kim
1,2*
1Department of Molecular Bioscience, College of Biomedical Science, 
2Medical & Bio-material Research Center, Kangwon National 
University, Chuncheon 200-701, Korea
Background: B cell-activating factor belonging to the TNF 
family (BAFF) is primarily expressed by macrophages and 
dendritic cells, and stimulates B cell proliferation, differ-
entiation, survival, and Ig production. In the present study, 
we explored the effect of activin A on BAFF expression by 
APCs. Methods: To investigate the effect of activin A on 
BAFF expression by mouse APCs, we measured the level of 
BAFF expression at the transcriptional and protein levels us-
ing RT-PCR and ELISA. Results: Activin A markedly en-
hanced BAFF expression in mouse macrophages and den-
dritic cells at both the transcriptional and protein levels. 
SB431542, an activin receptor-like kinase 4 (ALK4) inhibitor, 
completely abrogated activin A-induced BAFF transcription. 
Furthermore, overexpression of DN-Smad3 abolished acti-
vin-induced BAFF expression at the transcriptional and pro-
tein levels. Conclusion: These results demonstrate that acti-
vin A can enhance BAFF expression through ALK4-Smad3 
pathway.
[Immune Network 2011;11(4):196-202]
INTRODUCTION
Although Th cells have the most effect on B cell maturation 
and  differentiation  once  the  B  cells  recognize  protein  anti-
g e n s ,  i t  i s  i n c r e a s i n g l y  c l e a r  t h a t  a n t i g e n  p r e s e n t i n g  c e l l s  
(APCs)  directly  affect  B  cells.  APCs  enhance  B  cell  pro-
liferation and differentiation (1-5). B cell-activating factor be-
l o n g i n g  t o  t h e  T N F  f a m i l y  ( B A F F ;  a l s o  k n o w n  a s  T A L L - 1 ,  
THANK, BLyS, and zTNF4), derived from dendritic cells (DCs) 
and macrophages, plays an important role in mediating such 
effects (6,7). Further, it is involved in B cell survival and ma-
turation, germinal center formation, antibody production, and 
class-switching  recombination  (CSR)  (8-10).
    Activation-induced deaminase (AID) is indispensable for Ig 
CSR (11), and it has been demonstrated that BAFF induces 
AID expression (12). TGF-β1, a well-known switch factor for 
IgA  and  IgG2b  isotypes  (13-15),  stimulates  mouse  macro-
phages and DCs to express BAFF (16), suggesting that TGF-β1 
can  regulate  Ig  synthesis  indirectly. 
  A c t i v i n  A ,  a  m e m b e r  o f  t h e  T G F - β1  superfamily,  is  the 
dimeric protein composed of b subunits linked by a disulfide 
bond, that include activin A (bAbA), activin AB (bAbB), and 
activin B (bBbB) (17). It has overlapping biological activities 
with TGF-β1 (18) and signals through Smad proteins (19). 
We  have  shown  that  activin  A  stimulates  mouse  B  cells  to 
express  IgA  isotypes  (20).  Nevertheless,  it  is  not  known  if 
stimulatory  activity  of  activin  A  on  APCs  is  associated  with 
B  cell  activation  and  differentiation. 
    In the present study, we explored the effects of activin A 
on BAFF expression by APCs such as DCs and macrophages 
to  see  if  activin  A  regulates  B  cell  differentiation  indirectly 
by influencing APCs. We found that activin A can potentiate 
APCs to express BAFF through activation of the ALK4-Smad3 
pathways.Activin A-induced BAFF in APCs
Jae-Hee Kim, et al.
197 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 4 August 2011
MATERIALS AND METHODS
Reagents
Activin A, TGF-β1, GM-CSF and IL-4, anti-mouse BAFF anti-
bodies were purchased from R&D Systems (Minneapolis, MN, 
USA).  SB431542,  SB203580,  PD98059,  and  SP600125,  ABTS 
were  obtained  from  Sigma  Chemical  Co.  (St.  Louis,  MO, 
USA). 
Mice
BALB/c mice were purchased from Orient Co. Ltd (Gyeonggi- 
do, Korea) and maintained on an 8:16-h light:dark cycle in 
an animal environmental control chamber (Daehan Biolink. 
Co.,  Korea).  Animals  were  fed  Purina  Laboratory  Rodent 
Chow 5001 ad libitum. Eight- to twelve-week-old mice were 
used in this study. Animal care was in accordance with the 
institutional  guidelines  of  Kangwon  National  University. 
Culture of DCs and macrophages 
The mouse dendritic cell line DC2.4 and the mouse macro-
phage  cell  line  RAW264.7  were  cultured  in  DMEM  (2  mM 
Lglutamine; 100 U/ml penicillin; 100 g/ml streptomycin) plus 
10% fetal bovine serum (HyClone Labs, Logan, UT, USA) in 
a  humidified  CO2 i n c u b a t o r .  B o n e  m a r r o w  s t e m  c e l l s  w e r e 
isolated  from  BALB/c  mouse  femurs  and  cultured  with 
GM-CSF (10 ng/ml) and IL-4 (10 ng/ml). After 7 days, appear-
a n c e  o f  D C s  w a s  d e t e r m i n e d  w i t h  m o u s e  a n t i - C D 1 1 c  m A b  
(R&D System) by FACS. This procedure resulted in approx-
imately 80% CD11c positive cell population. For the prepara-
tion  of  peritoneal  macrophages,  mice  were  injected  with  3 
m l o f 4%  t hi og l yc o lat e  b ro th  i n PB S in tr ape ri to n ea lly .  A ft er 
72  h,  peritoneal  cells  were  harvested  by  peritoneal  lavage 
with PBS containing 2% FBS, washed twice with HBSS, re-
suspended in 10% FBS-DMEM, and dispensed in 100-mm cul-
ture  dishes.  Cells  were  incubated  in  a  CO2  incubator  for  2 
h  at  37
oC,  and  adherent  cells  were  used  as  peritoneal 
macrophages.
Preparation of Plasmids
A mouse BAFF promoter (pBAFF) was cloned in our labo-
ratory (16). The DN-Smad3 plasmid was provided by Dr. M. 
Kato  (The  Cancer  Institute,  Tokyo,  Japan).
Transfection and luciferase assays
T h e  r e p o r t e r  p l a s m i d s  w e r e  c o - t r a n s f e c t e d  w i t h  t h e  e x -
pression plasmids and pCMVβgal (Stratagene, La Jolla, CA) 
into DC2.4 cells by using a MicroPoratorTM MP-100 (Digital 
Bio  Technology,  Seoul,  Korea);  co-transfection  was  per-
formed according to the manufacturer's instructions. Briefly, 
2×10
6  cells were mixed with the reporter plasmid and the 
expression  plasmid and  pulsed twice at  1000 V for 30 ms. 
Luciferase and β-galactosidase assays were performed as de-
scribed  (21). 
RT-PCR
RNA  preparation,  reverse  transcription,  and  PCR  were  per-
formed as described (21). PCR primers were synthesized by 
Bioneer Corp. (Seoul, Korea). The primers for mouse BAFF 
were forward primer 5’-GCC GCC ATT CTC AAC ATG AT-3’ 
and reverse primer 5’-TTA GGG CAC CAA AGA AGG TG -3’ 
(product  size:  468,  409  bp).  All  reagents  for  RT-PCR  were 
purchased from Promega (Madison, WI, USA). PCR was also 
performed with β-actin to allow for normalization of cDNA 
concentrations in each set of samples. PCR products were re-
solved  by  electrophoresis  on  2%  agarose  gels.
ELISA for mouse BAFF
ELISA was performed as described previously (16). Anti-mouse 
BAFF antibody (2μg/ml) was added to 96 well microplates. 
After incubation overnight at 4
oC, the plates were washed and 
blocked with 1% gelatin for 1 h. Supernatant samples (50μl) 
or  standard  protein  (mouse  recombinant  BAFF)  diluted  in 
0.5%  gelatin  were  added  to  the  wells.  After  incubation  for 
1 h at 37
oC, the plates were washed again, and 2μg/ml mon-
oclonal anti-mouse BAFF antibody was added for 1 h at 37
oC. 
The plates were then washed and incubated with goat anti-rat 
IgG-HRP for 1 h. After washing, 0.2 mM ABTS was added 
to the wells, and 10 min later, the colorimetric reaction was 
measured  at  405  nm  with  a  VERSAmax  ELISA  reader 
(Molecular  Devices,  Sunnyvale,  CA,  USA).
Statistical analysis
Statistical differences between experimental groups were de-
termined  by  ANO-VAs,  and  values  of  p＜0.05  by  unpaired 
two-tailed  Student’s  t-test  were  considered  significant.
RESULTS AND DISCUSSION
Effect of activin A on BAFF expression by mouse DCs 
APCs are involved in B cell activation and differentiation (4,5) 
and BAFF is one of the important factors expressed by APCs 
such as macrophages and DCs (1,22,23). Since we have dem-Activin A-induced BAFF in APCs
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Figure 1. Activin A stimulates mouse DCs to express BAFF. (A) Effect of activin A on BAFF transcriptional levels in DC2.4 cells. DC2.4 cells 
(a mouse DC line) were treated with activin A (5, 10, and 20 ng/ml) for 24 h (left panel). Activin A (10 ng/ml) was added to the cell cultures 
for the indicated times (right panel). In all experiments, BAFF mRNA levels were determined by RT-PCR. Fold increase (Fold I.) values represent 
relative amounts of BAFF cDNA normalized to the expression of β-actin cDNA using Kodak Molecular Imaging software. (B) Effect of activin 
A on BAFF promoter activity. DC2.4 cells (1×10
6) were transfected with the pBAFF reporter (1μg). Cells were then stimulated with activin 
A (10 ng/ml) and luciferase activity was determined 24 h later. Transfection efficiency was normalized by β-gal activity. Data are average luciferase 
activities of two independent transfections with ranges (bars). (C) Effect of activin A on BAFF secretion. DC2.4 cells were treated activin A (10 
ng/ml). After 48 h of culture, supernatants were collected and the secreting form of BAFF was measured by ELISA. Data are means of triplicate 
samples±SEM. *p＜0.05; **p＜0.01. (D) Effect of activin A on the growth kinetics of DC2.4 cells. DC2.4 cells were cultured with activin A 
(10 ng/ml). Numbers of viable cells were enumerated by trypan blue exclusion. Data are means of triplicate samples±SEM.
Figure 2. Effect of activin A on BAFF expression by bone marrow-derived DCs. Freshly isolated bone marrow stem cells were differentiated 
and incubated with activin A (10 ng/ml). After 24 h of culture, levels of BAFF transcripts were determined by RT-PCR (left panel). After 48
h of culture, BAFF secretion was measured by ELISA (right panel). Data are means of triplicate samples±SEM. *p＜0.05.
onstrated that TGF-β1 stimulates mouse macrophages to ex-
pr es s B A F F  (1 6 ),  it  w as  w or th w hile  to investigate  if  activin 
A, a member of the TGF-β superfamily, can modulate APCs 
to express BAFF. To explore the possibility that activin A reg-Activin A-induced BAFF in APCs
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Figure 3. Activin A stimulates BAFF expression in mouse macrophage cells. (A) Effect of activin A on BAFF transcription in RAW264.7 cells.
RAW264.7 cells (a mouse macrophage cell line) were treated with TGF-β (1 ng/ml) and activin A (10 ng/ml) for 24 h (left panel). Effect of 
activin A on BAFF transcription as a function of time (right panel). Activin A (10 ng/ml) was added to the cell cultures for the indicated times.
Levels of BAFF mRNA were determined by RT-PCR. (B) Effect of activin A on BAFF expression by mouse peritoneal macrophages. Freshly isolated
mouse peritoneal macrophages were incubated with activin A (10 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR (left
panel). After 48 h of culture, BAFF secretion was measured by ELISA (right panel). Data are means of triplicate samples±SEM. **p＜0.01. 
ulates BAFF expression in mouse DCs, we first examined the 
effect of activin A on the levels of endogenous BAFF trans-
cripts.  Activin  A  induced  BAFF  transcription  in  the  mouse 
dendritic  cell  line,  DC2.4.  Optimal  induction  was  observed 
under conditions of 10 ng/ml activin A and 9-h stimulation 
(Fig. 1A). Similarly, activin A increased the promoter activity 
of BAFF (Fig. 1B). Since activin-A increased the BAFF tran-
scription and promoter activity, it was necessary to determine 
its effect at the protein level. Two types of BAFF are known 
to exist in a secreting and a membrane-bound form (22,7). 
Here, activin A increased the secretion of BAFF by DC2.4 for 
at least 48 hrs following stimulation (Fig. 1C). Concentration 
o f  a c t i v i n  A  ( i . e . ,  1 0  n g / m l ) ,  w h i c h  s i g n i f i c a n t l y  i n c r e a s e d  
BAFF expression, little affected cell growth as shown in Fig. 
1D.  These  results  indicate  that  activin  A  actually  regulates 
mouse  DCs  BAFF  gene  expression.  Further,  activin  A  also 
stimulated BAFF expression at the mRNA and protein levels 
in primary bone marrow-derived DCs (Fig. 2). Taken togeth-
er, our results clearly show that activin A stimulates mouse 
DCs  to  express  BAFF. 
Effect of activin A on BAFF expression by mouse 
macrophages
We proceeded to determine if activin A regulates BAFF ex-
pression in mouse macrophages. As shown in Fig. 3A, activin 
A significantly increased BAFF transcription in RAW264.7, a 
mouse macrophage cell line. BAFF transcript was detectable 
as early as 3 h after stimulation (Fig. 3A). These results are 
largely consistent with our early finding that TGF-β1 induces 
B A F F  i n  s u c h  c e l l  l i n e  ( 1 6 ) .  I n  p r i m a r y  p e r i t o n e a l  m a c r o -
phages, activin A also stimulated BAFF expression at both the 
transcriptional and protein levels (Fig. 3B). These results re-
veal  that,  in  mouse,  activin  A  not  only  stimulates  DCs  but 
also  macrophages  to  express  BAFF.Activin A-induced BAFF in APCs
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Figure 4. Activin A enhances BAFF expression through ALK4 and Smad3. (A) Activin A induces BAFF mRNA expression via ALK4. DC2.4 cells
were pre-treated with 10μM SB431542, 10μM SB203580, 10μM SP600125, or 5μM PD98059 for 1 h and then stimulated with activin A
(10 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR. (B) DC2.4 cells (1×10
6) were transfected with DN-Smad3 expression
vectors (2, 4, 8μg) and stimulated with activin A (10 ng/ml) for 24 h. Levels of BAFF transcripts were determined by RT-PCR. (C) BAFF secretion
by DN-Smad3-transfected DC 2.4 was measured by ELISA after 48 h incubation with activin A. Data are means of triplicate samples±SEM.
**p＜0.01. (D) Proposed mechanisms underlying activin A-induced BAFF expression in mouse APCs. Our results indicate that the ALK4 and
Smad3/4 mediate activin A-induced BAFF expression.
Involvement of the Smad pathway in activin A-indu-
ced BAFF expression
We subsequently investigated the mechanisms underlying ac-
tivin A-induced BAFF expression. Since the activin A signal 
activates not only ALK4/Smad pathway but also mitogen-acti-
vated protein kinases (MAPKs) pathway, such as p38MAPK, 
JNK,  and  ERK  (19,24-26,27),  we  asked  the  involvement  of 
ALK4/Smad pathway and MAPK pathway in activin A-induced 
BAFF  expression.  SB431542  (an  ALK4  inhibitor)  completely 
abrogated  activin  A-induced  BAFF  transcription,  whereas 
PD98059  (ERK  inhibitor),  SP600125  (JNK  inhibitor),  and 
SB203580 (p38 inhibitor) had little effect (Fig. 4A), suggesting 
that activin A induces BAFF expression through the ALK4 but 
not  MAPKs  pathway.  Further, activin A-induced BAFF  tran-
scription was abrogated by DN-Smad3 in a dose-dependent 
manner (Fig. 4B). This was paralleled by changes in BAFF 
e x p r e s s i o n  a t  t h e  p r o t e i n  l e v e l  ( F i g .  4 C ) .  T a k e n  t o g e t h e r ,  
these results indicate that ALK4-Smad3 pathway is mainly re-
sponsible for activin A induced BAFF expression (Fig. 4D).
    In summary, we demonstrate in the present study that acti-
vin A stimulates mouse APCs to produce BAFF and that this 
is attributed to ALK4-Smad3 signaling. BAFF is believed to be 
the most important macrophage- and DC-derived B cell-acti-
vating  factor (1). Among functions  of  BAFF,  it  can  activate 
B cells to express AID gene (28,29). We have recently dem-
onstrated  that  macrophage-derived  BAFF  induces  AID  ex-
pression in mouse B cells (30). Therefore, these in vitro stud-
ies imply that activin A causes APCs to produce BAFF, which 
may  have  important  effects  on  the  Ig  isotype  switching  in 
vivo. Activin A-induced BAFF in APCs
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